Clover Health Investments Corp. (NASDAQ:CLOV) went up by 1.47% from its latest closing price compared to the recent 1-year high of $17.45. The company’s stock price has collected 3.68% of gains in the last five trading sessions. Press Release reported 6 hours ago that SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Clover Health Investments, Corp. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 6, 2021 – CLOV
Is It Worth Investing in Clover Health Investments Corp. (NASDAQ :CLOV) Right Now?
Opinions of the stock are interesting as 2 analysts out of 4 who provided ratings for Clover Health Investments Corp. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 2 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $13.25, which is $5.06 above the current price. CLOV currently public float of 86.67M and currently shorts hold a 34.18% ratio of that float. Today, the average trading volume of CLOV was 16.44M shares.
CLOV’s Market Performance
CLOV stocks went up by 3.68% for the week, with a monthly drop of -2.93% and a quarterly performance of -51.25%. The volatility ratio for the week stands at 5.28% while the volatility levels for the past 30 days are set at 7.56% for Clover Health Investments Corp.. The simple moving average for the period of the last 20 days is -5.79% for CLOV stocks with a simple moving average of -31.52% for the last 200 days.
Analysts’ Opinion of CLOV
Many brokerage firms have already submitted their reports for CLOV stocks, with Credit Suisse repeating the rating for CLOV by listing it as a “Neutral.” The predicted price for CLOV in the upcoming period, according to Credit Suisse is $10 based on the research report published on March 09th of the current year 2021.
Citigroup, on the other hand, stated in their research note that they expect to see CLOV reach a price target of $19. The rating they have provided for CLOV stocks is “Buy” according to the report published on February 02nd, 2021.
JP Morgan gave a rating of “Neutral” to CLOV, setting the target price at $15 in the report published on February 01st of the current year.
CLOV Trading at -26.00% from the 50-Day Moving Average
After a stumble in the market that brought CLOV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -56.39% of loss for the given period.
Volatility was left at 7.56%, however, over the last 30 days, the volatility rate increased by 5.28%, as shares surge +3.54% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -43.84% lower at present.
During the last 5 trading sessions, CLOV rose by +3.68%, which changed the moving average for the period of 200-days by -28.21% in comparison to the 20-day moving average, which settled at $8.09. In addition, Clover Health Investments Corp. saw -54.62% in overturn over a single year, with a tendency to cut further losses.